Han X P,Li Z B,Sun J,et al.Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery:Probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation[J].J Controlled Release,2015,197:29-40.
[2]
Platt V M,Szoka F C Jr.Anticancer therapeutics:Targeting macromolecules and nanocarriers to hyaluronan or CD44,a hyaluronan receptor[J].Mol Pharm,2008,5(4):474-486.
[3]
Gong X Y,Yin Y H,Huang Z J,et al.Preparation,characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan[J].Int J Pharm,2012,436(1-2):240-247.
[4]
Song G,Liao X,Zhou L,et al.HI44a,an anti-CD44monoclonal antibody,induces differentiation and apoptosis of human acute myeloid leukemia cells[J].Leuk Res,2004,28(10):1089-1096.
[5]
Almalik A,Day P J,Tirelli N.HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery[J].Macromol Biosci,2013,13(12):1671-1680.
[6]
Doerr I,Wempen I,Clarke D,et al.Thiation of nucleosides.Ⅲ.Oxidation of 6-mercaptopurines[J].J Org Chem,1961,26(9):3401-3409.
[7]
Zacchigna M,Cateni F,Di Luca G,et al.A simple method for the preparation of PEG-6-mercaptopurine for oral administration[J].Bioorg Med Chem Lett,2007,17(23):6607-6609.
[8]
Luo Y,Ziebell M R,Prestwich G D.A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells[J].Biomacromolecules,2000,1(2):208-218.
[9]
Zacchigna M,Cateni F,Di Luca G,et al.A simple method for the preparation of PEG-6-mercaptopurine for oral administration[J].Bioorg Med Chem Lett,2007,17(23):6607-6609.
[10]
Jorgensen L,McKerrall S J,Kuttruff C A,et al.14-step synthesis of(+)-ingenol from(+)-3-carene[J].Science,2013,341(6148):878-882.
[11]
Lu Z,Li Y,Deng J,et al.Total synthesis of the daphniphyllum alkaloid daphenylline[J].Nature chemistry,2013,5(8):679-684.
[12]
van der Vlies A J,Hasegawa U,Hubbell J A.Reduction-sensitive tioguanine prodrug micelles[J].Mol Pharm,2012,9(10):2812-2818.